| Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement SA Ahyai, P Gilling, SA Kaplan, RM Kuntz, S Madersbacher, F Montorsi, ... European urology 58 (3), 384-397, 2010 | 828 | 2010 |
| Bladder outflow obstruction—a cause of denervation supersensitivity MJ Speakman, AF Brading, CJ Gilpin, JS Dixon, SA Gilpin, JA Gosling The Journal of urology 138 (6), 1461-1466, 1987 | 387 | 1987 |
| EAU guidelines on management of non-neurogenic male lower urinary tract symptoms (LUTS), incl. benign prostatic obstruction (BPO) S Gravas, JN Cornu, M Gacci, C Gratzke, TRW Herrmann, C Mamoulakis, ... | 321* | 2020 |
| Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH)–focus on the UK M Speakman, R Kirby, S Doyle, C Ioannou BJU international 115 (4), 508-519, 2015 | 302 | 2015 |
| Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity‐matched comparison with transurethral resection of … AF Ray, J Powell, MJ Speakman, NT Longford, R DasGupta, T Bryant, ... BJU international 122 (2), 270-282, 2018 | 263 | 2018 |
| Prospective, randomized, multinational study of prostatic urethral lift versus transurethral resection of the prostate: 12-month results from the BPH6 study J Sønksen, NJ Barber, MJ Speakman, R Berges, U Wetterauer, D Greene, ... European urology 68 (4), 643-652, 2015 | 253 | 2015 |
| Prostatic urethral lift vs transurethral resection of the prostate: 2‐year results of the BPH 6 prospective, multicentre, randomized study C Gratzke, N Barber, MJ Speakman, R Berges, U Wetterauer, D Greene, ... BJU international 119 (5), 767-775, 2017 | 210 | 2017 |
| A chaos theory perspective on destination crisis management: Evidence from Mexico M Speakman, R Sharpley Journal of Destination Marketing & Management 1 (1-2), 67-77, 2012 | 190 | 2012 |
| Tamsulosin 0.4 mg once daily: effect on sexual function in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction K Höfner, H Claes, TM De Reijke, B Folkestad, MJ Speakman European urology 36 (4), 335-341, 1999 | 185 | 1999 |
| British Society for Sexual Medicine guidelines on the management of erectile dysfunction G Hackett, P Kell, D Ralph, J Dean, D Price, M Speakman, K Wylie The journal of sexual medicine 5 (8), 1841-1865, 2008 | 182 | 2008 |
| Guideline for the primary care management of male lower urinary tract symptoms MJ Speakman, RS Kirby, A Joyce, P Abrams, R Pocock BJU international 93 (7), 985-990, 2004 | 154 | 2004 |
| Combination therapy with solifenacin and tamsulosin oral controlled absorption system in a single tablet for lower urinary tract symptoms in men: efficacy and safety results … P van Kerrebroeck, C Chapple, T Drogendijk, M Klaver, R Sokol, ... European urology 64 (6), 1003-1012, 2013 | 144 | 2013 |
| Randomised controlled trial of pelvic floor muscle exercises and manometric biofeedback for erectile dysfunction G Dorey, M Speakman, R Feneley, A Swinkels, C Dunn, P Ewings British Journal of General Practice 54 (508), 819-825, 2004 | 143 | 2004 |
| A dose‐ranging study of the efficacy and safety of tamsulosin, the first prostate‐selective α1A‐adrenoceptor antagonist*, in patients with benign prostatic obstruction P Abrams, M Speakman, M Stott, D Arkell, R Pocock British journal of urology 80 (4), 587-596, 1997 | 132 | 1997 |
| Tamsulosin, the First Prostate-Selective α (1A)-Adrenoceptor Antagonist CC Schulman, J Cortvriend, U Jonas, T Lock, S Vaage, MJ Speakman European urology 29 (2), 145-154, 1996 | 122 | 1996 |
| Durable efficacy and safety of long-term onabotulinumtoxinA treatment in patients with overactive bladder syndrome: final results of a 3.5-year study VW Nitti, D Ginsberg, KD Sievert, D Sussman, S Radomski, P Sand, ... The Journal of urology 196 (3), 791-800, 2016 | 111 | 2016 |
| Pelvic floor exercises for erectile dysfunction G Dorey, MJ Speakman, RCL Feneley, A Swinkels, CDR Dunn BJU international 96 (4), 595-597, 2005 | 110 | 2005 |
| The effects of cromakalim on the detrusor muscle of human and pig urinary bladder CD Foster, MJ Speakman, K Fujii, AF Brading British journal of urology 63 (3), 284-294, 1989 | 110 | 1989 |
| Erectile dysfunction and lower urinary tract symptoms: a consensus on the importance of co‐diagnosis M Kirby, C Chapple, G Jackson, I Eardley, D Edwards, G Hackett, D Ralph, ... International journal of clinical practice 67 (7), 606-618, 2013 | 109 | 2013 |
| EAU guidelines on management of non-neurogenic male lower urinary tract symptoms (LUTS), incl S Gravas, JN Cornu, M Gacci, C Gratzke, TRW Herrmann, C Mamoulakis, ... Benign prostatic obstruction (BPO), 1-112, 2020 | 106 | 2020 |
